ABSTRACT
A new 7-(diethylamino)-2-oxo-2 H-chromene-3-carbohydrazide design to synthesize a simple Schiff-base condition. The synthesized molecules' (probe L) photophysical properties were investigated in various solvent systems and solvent-poor-solvent assays. Probe L exhibits the absorbance band at 440 nm and the emission band at 488 nm in DMSO: H2O (7:3, v/v). Further, probe L shows selective turn-off emission recognition of In3+ ions in DMSO: H2O (7:3, pH = 7.4). By Job's plot and ESI mass analysis, probe L forms a 1:2 stoichiometry complex with an estimated association constant of 4.04 × 104 M- 2 with In3+ ions. Metal induces CHEQ (chelation-caused fluorescence quenching) to reduce the intensity of probe L's emission, and the estimated quenching constant was 4.52 × 104 M- 1. The limit of detection was found to be 5.93 nM; the time response of the sensor is instantaneous, and its reversible nature was confirmed using EDTA additions. Solid substrates (test strips) were designed and tested for fast, reliable, user-friendly, and real-time sensing of In3+ ions for on-site applications. The binding mechanism of probe L with In3+ ions was investigated using 1H NMR titration and DFT/TD-DFT studies.
ABSTRACT
The recent COVID-19 outbreak caused by the novel coronavirus SARS-CoV-2 has an immense impact on global health and economy. Although vaccines are being used, urgent need of drugs based on natural products with high efficacy and safety is a pressing priority. Quinoline alkaloids are well known for their therapeutic action against malaria; initially, it was tried against Coronaviruses. It is a basic vital scaffold to design drugs with required biological and pharmacological activities. In this present study, a new quinoline compound was synthesized and characterized by spectroscopy techniques. Crystal structure was established by SCXRD analysis and data is used as an input to perform various computations. Additionally, using state-of-the-art quantum computational techniques, the geometry optimization and calculation of UV-Vis spectrum of 2F6M3CQ were performed at B3LYP/6-311G* level of theory. The optimized molecular geometric parameters as well as UV-Vis spectrum values are found to be in good agreement with their respective experimental results. The visualization of 3-D plots of FMO and MEP indicated the structure and reactivity trends of 2F6M3CQ molecule. Molecular docking methods were utilized to find the drug ability of 2F6M3CQ with Mproprotein of SARS-CoV-2. There were many intermolecular interactions between Mpro protein and 2F6M3CQ molecule which lead to good binding energy (-5.5 kcal/mol) between them which was found to be better than the binding energy of chloroquinine molecule (-4.5 kcal/mol) as studied under same docking protocols. Finally, drug likeness and ADME properties of 2F6M3CQ were also analyzed. There is no violation found for RO5 in our 2F6M3CQ compound. ADME analysis shows drug like properties of compound 2F6M3CQ which predicts that it might be a potential candidate for inhibition of SARS-CoV-2.
ABSTRACT
Determining the mutational status of susceptibility genes including RET, VHL, SDHx (SDHB, SDHC, SDHD) among patients with pheochromocytoma/paraganglioma (PCC/PGL) is gaining importance. These genes have not been systematically characterized among patients with PCC/PGL from India. The aim of the work was to screen the most frequently mutated genes among patients with PCC/PGL to determine the frequency and spectrum of mutations seen in this region. Fifty patients with PCC/PGL treated at our tertiary care hospital between January 2010 and June 2012 were screened for mutations in susceptibility genes using an algorithmic approach. Thirty-two percent (16/50) of patients were found to be positive for mutations including mutations among RET (n=4), VHL (n=6), SDHB (n=3), and SDHD (n=3) genes. None of these patients were positive for SDHC mutations. A significant association was found between young patients with bilateral tumors and VHL mutations (p=0.002). Two of the 3 patients with extra-adrenal SDHB associated tumors, had unique mutations, viz., c.436delT (exon 5) and c.788_857del (exon 8), one of which was malignant. High frequency of mutations seen among patients in this study emphasizes the need to consider mutational analysis among Indian patients with PCC/PGL.
